Important questions are \u27Is the drug worth paying for?\u27 and \u27Is the drug affordable within limited budgets?\u27 To answer these questions, decision-makers need to assess the clinical benefits and costs of newer and existing drugs. It is obvious that clinical benefits and costs of drugs should be assessed in an organized way rather than using an informal assessment, such as \u27educated guess\u27 or \u27what we did last time.\u27 Pharmacoeconomics provides systematic approaches to assess the clinical benefit and cost of drugs in a comparative manner.https://digitalcommons.chapman.edu/pharmacy_books/1022/thumbnail.jp
The article presents pharmacoeconomics is an essential component of health technology assessment and...
The financial constraints faced by most health systems today make it necessary for manufacturers of ...
pharmacy bookfair2015Includes bibliographical references and index.xvi, 295 pages :This text provide...
Pharmacoeconomics is the description and analysis of the costs of drug therapy to healthcare systems...
Efficacy and safety are crucial considerations in judging drugs, for example, whether or not to incl...
In the last years, the growing interest of healthcare professionals, policy-makers, and other stakeh...
Pharmacoeconomics identifies, measures, and compares the costs and consequences of drug therapy to h...
Pharmacoeconomics identifies, measures, and compares the costs and consequences of drug therapy to h...
The results of a study on the use of pharmacoeconomic analysis to justify the rational choice of dru...
Health care funders (governments, social security funds, insurance companies) are struggling to meet...
The pharmacoeconomics is relatively new ˆeld in pharmaceutical science. In August, Pharmaceutical So...
AbstractBy today, in our business environment, mostly based on innovation, the potential opportuniti...
Pharmacoeconomic evaluation is an analysis technique that combines data on both costs and health out...
The role of cost- and pharmacoeconomic-related criteria in formulary decision-making was assessed in...
A research report submitted to the Faculty of Health Sciences, University of the Witwatersrand, Joha...
The article presents pharmacoeconomics is an essential component of health technology assessment and...
The financial constraints faced by most health systems today make it necessary for manufacturers of ...
pharmacy bookfair2015Includes bibliographical references and index.xvi, 295 pages :This text provide...
Pharmacoeconomics is the description and analysis of the costs of drug therapy to healthcare systems...
Efficacy and safety are crucial considerations in judging drugs, for example, whether or not to incl...
In the last years, the growing interest of healthcare professionals, policy-makers, and other stakeh...
Pharmacoeconomics identifies, measures, and compares the costs and consequences of drug therapy to h...
Pharmacoeconomics identifies, measures, and compares the costs and consequences of drug therapy to h...
The results of a study on the use of pharmacoeconomic analysis to justify the rational choice of dru...
Health care funders (governments, social security funds, insurance companies) are struggling to meet...
The pharmacoeconomics is relatively new ˆeld in pharmaceutical science. In August, Pharmaceutical So...
AbstractBy today, in our business environment, mostly based on innovation, the potential opportuniti...
Pharmacoeconomic evaluation is an analysis technique that combines data on both costs and health out...
The role of cost- and pharmacoeconomic-related criteria in formulary decision-making was assessed in...
A research report submitted to the Faculty of Health Sciences, University of the Witwatersrand, Joha...
The article presents pharmacoeconomics is an essential component of health technology assessment and...
The financial constraints faced by most health systems today make it necessary for manufacturers of ...
pharmacy bookfair2015Includes bibliographical references and index.xvi, 295 pages :This text provide...